Experimental immunity to a metabolite of halothane and fluroxene: cutaneous delayed-type hypersensitivity.
D000418:Albumins; D000818:Animals; D001711:Biotransformation; D002417:Cattle; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology / Q000276:immunology; D004195:Disease Models, Animal; D004342:Drug Hypersensitivity / Q000276:immunology* / Q000473:pathology; D004890:Erythema / Q000473:pathology; D004987:Ethers / Q000009:adverse effects*; D005463:Fluoroacetates / Q000009:adverse effects*; D005612:Freeze Drying; D006168:Guinea Pigs; D006221:Halothane / Q000009:adverse effects*; D006241:Haptens; D006801:Humans; D007111:Immunity, Cellular; D007271:Injections, Intradermal; D008213:Lymphocyte Activation; D008297:Male; D009336:Necrosis; D012709:Serum Albumin; D012710:Serum Albumin, Bovine; D012882:Skin Tests
D000418:Albumins; D004987:Ethers; D005463:Fluoroacetates; D006241:Haptens; D012709:Serum Albumin; D012710:Serum Albumin, Bovine; D006221:Halothane